trimebutine has been researched along with Spasm in 1 studies
Trimebutine: Proposed spasmolytic with possible local anesthetic action used in gastrointestinal disorders.
Spasm: An involuntary contraction of a muscle or group of muscles. Spasms may involve SKELETAL MUSCLE or SMOOTH MUSCLE.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In the double-blind segment, 69 patients with chronic gastro-intestinal spasmodic conditions were allocated, according to a pre-set randomization table, to receive orally 3 daily doses of fenoverine (100 mg; 35 patients), trimebutine (150 mg; 14 patients) or placebo (20 patients) during an average of 8 days." | 5.06 | Fenoverine: a two-step, double-blind and open clinical assessments of its smooth muscle synchronizing effects. ( Bader, F, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bader, F | 1 |
1 trial available for trimebutine and Spasm
| Article | Year |
|---|---|
Fenoverine: a two-step, double-blind and open clinical assessments of its smooth muscle synchronizing effects.
Topics: Administration, Oral; Adult; Aged; Benzoates; Biliary Dyskinesia; Clinical Trials as Topic; Double-B | 1986 |